Matthew Kurian: Incredible experience at the KYSCO Conference
Matthew Kurian shared the following on LinkedIn:
“What an incredible experience at the KYSCO Conference this year!
The energy, the insights, and the expertise shared by so many talented speakers made it truly engaging from start to finish. From groundbreaking research presentations to interactive sessions, it was inspiring to see how our field continues to innovate and make a difference.
A huge thank you to all the speakers, sponsors, and organizers who made this event a success!
As part of the KYSCO executive board, I would like to extend the invitation to all to join us at our next joint meeting with the Tennessee Oncology State Society to discuss the evolution of immunotherapy and cellular therapy in all tumor types on February 14–15 in Bowling Green, KY. Should be a great event!”
Matthew Kurian is a staff hematology/oncology physician at St. Elizabeth Healthcare and an assistant professor of medicine at the University of Kentucky College of Medicine. His primary focus lies in breast and genitourinary (GU) cancers, where he combines clinical practice with research to improve patient outcomes. Dr. Kurian has expertise in radioligand treatments, including Lu-177, and has published several peer-reviewed articles on various oncology topics.
He completed his oncology fellowship at the NCI-designated University Hospitals/Case Comprehensive Cancer Center, where he also served as the Chief Fellow of the Hematology/Oncology Fellowship Program for the 2022-2023 academic year.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023